Bank of America’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5K | Buy |
3,524
+181
| +5% | +$590 | ﹤0.01% | 6139 |
|
|
2025
Q1 | $6.85K | Buy |
3,343
+45
| +1% | +$92 | ﹤0.01% | 6135 |
|
|
2024
Q4 | $7.26K | Buy |
3,298
+8
| +0.2% | +$18 | ﹤0.01% | 6120 |
|
|
2024
Q3 | $5.56K | Hold |
3,290
| – | – | ﹤0.01% | 6064 |
|
|
2024
Q2 | $8.03K | Buy |
+3,290
| New | +$8.03K | ﹤0.01% | 6043 |
|
|
2024
Q1 | – | Sell |
-7
| Closed | -$34 | – | 6974 |
|
|
2023
Q4 | $34 | Buy |
+7
| New | +$34 | ﹤0.01% | 6602 |
|
|
2023
Q3 | – | Sell |
-3,000
| Closed | -$14.5K | – | 6881 |
|
|
2023
Q2 | $14.5K | Hold |
3,000
| – | – | ﹤0.01% | 5903 |
|
|
2023
Q1 | $19.8K | Sell |
3,000
-581
| -16% | -$3.83K | ﹤0.01% | 5943 |
|
|
2022
Q4 | $39.7K | Buy |
3,581
+3,548
| +10,752% | +$39.4K | ﹤0.01% | 5770 |
|
|
2022
Q3 | $0 | Buy |
33
+1
| +3% | – | ﹤0.01% | 7089 |
|
|
2022
Q2 | $0 | Sell |
32
-117
| -79% | – | ﹤0.01% | 7300 |
|
|
2022
Q1 | $3K | Sell |
149
-288
| -66% | -$5.8K | ﹤0.01% | 7159 |
|
|
2021
Q4 | $21K | Sell |
437
-1,499
| -77% | -$72K | ﹤0.01% | 6637 |
|
|
2021
Q3 | $179K | Buy |
+1,936
| New | +$179K | ﹤0.01% | 5532 |
|